EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Naveen Pemmaraju, Eric Deconinck, Priyanka Mehta, Irwin Walker, Marco Herling, Francine Garnache-Ottou, Nadia Gabarin, Clinton J V Campbell, Johannes Duell, Yakir Moshe, Tariq Mughal, Mohamad Mohty und 1 weitere

Clinical Lymphoma Myeloma and Leukemia · 2024-04 · 24 (4) · e130-e137

DOI: 10.1016/j.clml.2023.12.010 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2024-04. Verfasst von Naveen Pemmaraju und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: npemmaraju@mdanderson.org. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Myeloproliferative Disorders, Skin Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsMyeloproliferative DisordersSkin NeoplasmsAdultHumansMiddle AgedInterleukin-3 Receptor alpha SubunitInterleukin-3Precision MedicineAcute DiseaseDendritic CellsBiology

Stichwörter der Autor:innen

BPDCNClinical casesMyeloid malignancyPrecision oncologyTagraxofusp

Substanzen

Interleukin-3 Receptor alpha SubunitInterleukin-3

Autor:innen und Institutionen

  • Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: npemmaraju@mdanderson.org.
  • Department of Hematology, CHU Besançon, Besançon Cedex, France; INSERM, UMR1098 RIGHT, Franche-Comté University, Établissement Français du Sang, Besançon, France.
  • Department of Haematology, University Hospitals of Bristol and Weston, NHS Foundation Trust, Bristol, United Kingdom.
  • Department of Medicine, McMaster University, Hamilton, ON, Canada; Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada.
  • Department of Hematology, Cellular Therapy, and Hemostaseology, University of Leipzig, Leipzig, Germany.
  • University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France; Etablissement Français du Sang Bourgogne Franche-Comté, Laboratoire d'Hé…

Zitieren

APA

Pemmaraju, N., Deconinck, E., Mehta, P., Walker, I., Herling, M., Garnache-Ottou, F., Gabarin, N., Campbell, C. J. V., Duell, J., Moshe, Y., Mughal, T., Mohty, M., & Angelucci, E. (2024). Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Clinical Lymphoma Myeloma and Leukemia, 24(4), e130-e137. https://doi.org/10.1016/j.clml.2023.12.010

Vancouver

Pemmaraju N, Deconinck E, Mehta P, Walker I, Herling M, Garnache-Ottou F, et al. Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Clinical Lymphoma Myeloma and Leukemia. 2024;24(4):e130-e137. doi:10.1016/j.clml.2023.12.010

BibTeX
@article{Pemmaraju2024,
  author = {Pemmaraju, Naveen and Deconinck, Eric and Mehta, Priyanka and Walker, Irwin and Herling, Marco and Garnache-Ottou, Francine and Gabarin, Nadia and Campbell, Clinton J V and Duell, Johannes and Moshe, Yakir and Mughal, Tariq and Mohty, Mohamad and Angelucci, Emanuele},
  title = {Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2024},
  volume = {24},
  number = {4},
  pages = {e130--e137},
  doi = {10.1016/j.clml.2023.12.010}
}
Kostenlos starten →